Lipid signalling enforces functional specialization of Treg cells in tumours.
Ontology highlight
ABSTRACT: Regulatory T cells (Treg cells) are essential for immune tolerance1, but also drive immunosuppression in the tumour microenvironment2. Therapeutic targeting of Treg cells in cancer will therefore require the identification of context-specific mechanisms that affect their function. Here we show that inhibiting lipid synthesis and metabolic signalling that are dependent on sterol-regulatory-element-binding proteins (SREBPs) in Treg cells unleashes effective antitumour immune responses without autoimmune toxicity. We find that the activity of SREBPs is upregulated in intratumoral Treg cells. Moreover, deletion of SREBP-cleavage-activating protein (SCAP)-a factor required for SREBP activity-in these cells inhibits tumour growth
SUBMITTER: Lim SA
PROVIDER: S-EPMC8168716 | biostudies-literature | 2021 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA